ABVC BIOPHARMA INC (ABVC)

US00091F3047 - Common Stock

1.08  0 (0%)

After market: 1.06 -0.02 (-1.85%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
152.43K970.00K360.00K480.00K700.00K
Minority Interest Expense
394.63K-110.00K-800.00K800.00K290.00K
Cost Of Goods
302.04K290.00K10.00K20.00K20.00K
Gross Profit
-149.61K680.00K350.00K460.00K680.00K
Operating Expenses
8.07M15.79M12.05M8.97M4.14M
Research and Development
1.06M2.69M1.00M550.00K1.05M
Selling, General, and Administrative Expenses
7.00M13.10M11.05M8.42M3.09M
Operating Income
-8.22M-15.11M-11.71M-8.51M-3.46M
Interest Income/Expense
-2.51M-370.00K-30.00K-1.55M-670.00K
Other Income/Expense
69.28K80.00K520.00K200.00K120.00K
Non Recurring Items
0.00-110.00K0.00-960.00KN/A
Income Before Taxes
-10.65M-15.51M-11.21M-10.81M-4.01M
Income Tax
256.01K800.00K830.00K-220.00K-80.00K
Net Income
-10.52M-16.42M-12.84M-9.79M-3.64M
EBITDA
-8.19M-15.09M-11.70M-8.47M-3.40M
 
Per Share Data
EPS Diluted Total Ops
-2.43-5.19-5.12-4.97-2.08
 
Statistics
Gross Profit Margin
-98.15%70.10%97.22%95.83%97.14%
Profit Margin
-6898.68%-1692.78%-3566.67%-2039.58%-520.00%
Operating Profit Margin
-5390.35%-1557.73%-3252.78%-1772.92%-494.29%

All data in USD

Charts